JPS6163294A - Production of hyaluronic acid through fermentation process - Google Patents

Production of hyaluronic acid through fermentation process

Info

Publication number
JPS6163294A
JPS6163294A JP18609084A JP18609084A JPS6163294A JP S6163294 A JPS6163294 A JP S6163294A JP 18609084 A JP18609084 A JP 18609084A JP 18609084 A JP18609084 A JP 18609084A JP S6163294 A JPS6163294 A JP S6163294A
Authority
JP
Japan
Prior art keywords
hyaluronic acid
culture solution
cultivation
saccharide
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP18609084A
Other languages
Japanese (ja)
Inventor
Yutaka Morita
裕 森田
Masashi Ushiyama
正志 牛山
Masahiro Fujii
正弘 藤井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JNC Corp
Original Assignee
Chisso Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp filed Critical Chisso Corp
Priority to JP18609084A priority Critical patent/JPS6163294A/en
Publication of JPS6163294A publication Critical patent/JPS6163294A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:A microorganism producing hyaluronic acid is cultured, as the culture medium is controlled within a specific pH range, and, a saccharide is further added, when the pH exceeds a certain value to continue the cultivation, whereby mass production of hyaluronic acid becomes possible. CONSTITUTION:In the cultivation of a microorganism producing hyaluronic acid such as Streptococcus pyogeness, the cultivation is carried out so that the pH of the medium may not lower than a specific value ranging from 6.5-7.5, preferably 7.0. When the pH exceeds 7.5, a saccharide is added to continue the cultivation to effect accumulation of hyaluronic acid in the medium. Since the pH of the culture mixture becomes lower as hyarulonic acid is formed, it is controlled by adding aqueous alkali. When the growth of the microorganism stops, the pH rises and at this time, 2-7%, preferably 5% of a saccharide is added.

Description

【発明の詳細な説明】 本発明はヒアルロン酸の発酵法による製造法に関する。[Detailed description of the invention] The present invention relates to a method for producing hyaluronic acid by fermentation.

ヒアルロン酸は関節、硝子体、贋帯、軟骨、皮膚、鳥類
のトサカなどの結合組織中にその構成成分として存在し
、該結合組織の柔軟性、構造保持、細胞の代謝調節など
に重要な機能を果たしている。また該ヒアルロン酸は非
常に大きな高分子物質であり、その溶液は強い粘弾性を
持っているので、化粧品、創傷治療薬、眼科薬、関節症
治療薬として巾広い用途がある。
Hyaluronic acid exists as a component in connective tissues such as joints, vitreous body, vitreous tissue, cartilage, skin, and the crest of birds, and has important functions such as maintaining the flexibility and structure of these connective tissues, and regulating cell metabolism. is fulfilled. In addition, hyaluronic acid is a very large polymeric substance, and its solution has strong viscoelasticity, so it has a wide range of uses as cosmetics, wound treatment agents, ophthalmic agents, and arthropathy treatment agents.

従来、該ヒアルロン酸はニワトリのトサカ、牛の眼の硝
子体または贋帯、関節液等より抽出法により得られてい
る。
Conventionally, the hyaluronic acid has been obtained by extraction methods from chicken combs, cow eye vitreous or fake tissue, synovial fluid, and the like.

しかし、これら生体から抽出法により得たヒアルロン酸
ハ、蛋白質やコンドロイチン等のムコ多糖類と複合体を
形成しているためその分離精製が非常に困難で、またか
かる生体からの抽出法で得たヒアルロン酸にはヒアルロ
ニダーゼが混在することが多いので抽出、精製工程中で
該ヒアルロン酸が分解されて分子量が低下し、その結果
、粘度および保水性が低くなるといった欠点を有してい
る。
However, it is very difficult to separate and purify hyaluronic acid obtained from these living organisms because it forms a complex with proteins and mucopolysaccharides such as chondroitin. Since hyaluronic acid often contains hyaluronidase, the hyaluronic acid is decomposed during the extraction and purification process, resulting in a decrease in molecular weight, resulting in a disadvantage of low viscosity and water retention.

これらの欠点を改良するために、ヒアルロン酸を生産す
る能力を有する微生物(以下、ヒアルロン酸生産菌とい
う。)を培養し、該培養液から直接該ヒアルロン酸を抽
出し、精製する方法が特開昭58−56692号公報に
開示されている。
In order to improve these shortcomings, a method of culturing microorganisms that have the ability to produce hyaluronic acid (hereinafter referred to as hyaluronic acid-producing bacteria), and directly extracting and purifying the hyaluronic acid from the culture solution has been disclosed. It is disclosed in Publication No. 58-56692.

この方法はヒアルロニダーゼを含まないヒアルロン酸生
産菌を培養してヒアルロン酸を得る方法なので、前述の
生体からの抽出法にくらべて製法が簡単でコストも安く
できるなどの利点がある。しかしこの発酵法によるヒア
ルロン酸の製造法は培養に長時間すなわち4〜6日間を
要し、かつ培養液1)当りのヒアルロン酸の生産量が0
.3〜1. ON程度と少ないのが欠点である。
Since this method obtains hyaluronic acid by culturing hyaluronic acid-producing bacteria that do not contain hyaluronidase, it has the advantage of being simpler and cheaper than the above-mentioned extraction method from living organisms. However, this fermentation method for producing hyaluronic acid requires a long time for culturing, that is, 4 to 6 days, and the production amount of hyaluronic acid per culture solution 1) is 0.
.. 3-1. The drawback is that it is only ON.

本発明者らは、このヒアルロン酸の生産性の低さの改善
に取り組み鋭意研究を重ねた。その結果、ヒアルロン酸
生産菌を培養するに当り、該培養液のPHを6.5以上
7.5未満の範囲の指定したPH以下にならないように
自動的にPHの連続制御をしながら該ヒアルロン酸生産
菌を培養し、該PHが7.5以上になった時点で該培養
液にさらに糖類を添加して培養することによりヒアルロ
ン酸の生産性を大巾に向上させることができることを見
い出し、本発明を完成した。
The present inventors have conducted extensive research in an effort to improve this low productivity of hyaluronic acid. As a result, when culturing hyaluronic acid-producing bacteria, the pH of the culture solution is automatically and continuously controlled so as not to fall below a specified pH in the range of 6.5 or more and less than 7.5. We have discovered that the productivity of hyaluronic acid can be greatly improved by culturing acid-producing bacteria and adding saccharides to the culture solution when the pH reaches 7.5 or higher, The invention has been completed.

以上の記述から明らかなように本発明の目的は発酵法に
よるヒアルロン酸の製造において、該ヒアルロン酸の生
産性を大巾に改善することのできる製造法を提供するこ
とである。
As is clear from the above description, an object of the present invention is to provide a method for producing hyaluronic acid by a fermentation method, which can greatly improve the productivity of hyaluronic acid.

本発明は以下の構成を有する。The present invention has the following configuration.

ヒアルロン酸を生産する能力を有する微生物を培養液中
で培養するにあたり、培養液PHを6.5以上7.5未
満の指定したPH以下にならないように自動的にPHの
連続制御をしながら培養し、PHが7.5以上になった
時点で糖類をさらに添加して培養することによって培養
液中にヒアルロン酸を生成蓄積せしめることを特徴とす
る発酵法によるヒアルロン酸の製造法。
When culturing microorganisms that have the ability to produce hyaluronic acid in a culture solution, the pH of the culture solution is automatically continuously controlled so that it does not fall below a specified pH of 6.5 or more and less than 7.5. A method for producing hyaluronic acid by a fermentation method, characterized in that hyaluronic acid is produced and accumulated in the culture solution by further adding saccharides and culturing when the pH reaches 7.5 or more.

本発明に用いるヒアルロン酸生産菌としては、  8ス
トレプトコツカス・ピオゲネス(Streptococ
cuspyogenes ) 、ストレプトコッカス・
エクイ(Streptococcus equi ) 
、ストレプトコッカスQエクイシミリス(Strept
ococcus equisimil is )、スト
レプトコッカス・ディスガラクチイエ(Strepto
coccusdysgalact iae )、ストレ
プトコッカス−ズーエピデミカス(5treptoco
ccus zooepidemicus )、パスツレ
ラ−マルトシダ(Pasteurella multo
cida )などをあげることができる。
The hyaluronic acid-producing bacteria used in the present invention include 8 Streptococcus pyogenes (Streptococcus pyogenes).
cuspyogenes), Streptococcus
Streptococcus equi
, Streptococcus Q equisimilis (Strept.
ococcus equisimil is), Streptococcus dysgalactiae (Streptococcus
coccusdysgalactiae), Streptococcus zooepidemicus (5treptococcus
ccus zooepidemicus ), Pasteurella multocida (Pasteurella multocida)
cida), etc.

本発明で用いられる培養液は通常の微生物の培養に用い
る培養液でよく、また該培養液の1成分として血清を添
加してもよい。該培養液を具体的に例示すると、例えば
、ブドウ糖2.0%、リン酸1カリウム0: 3 % 
、  リン酸2カリウム0.2チ、チオ硫酸ナトリウム
0.01 %、硫酸マグネシラ”ム7水塩o、 o 1
%、亜硫酸ナトリウム0.002チ(ただし以上のチは
重t/容量チをあられす。)に修生血清1,5容tチを
加えたものを用いることができる。
The culture solution used in the present invention may be a culture solution used for the cultivation of ordinary microorganisms, and serum may be added as a component of the culture solution. A specific example of the culture solution is, for example, 2.0% glucose, 0:3% monopotassium phosphate.
, dipotassium phosphate 0.2%, sodium thiosulfate 0.01%, magnesium sulfate heptahydrate o, o 1
%, sodium sulfite (0.002 t) (however, the above amount should be 1.5 t/vol.) and 1.5 t/t of revitalized serum can be used.

また本発明の培養では、培養液の通気撹拌培養、振とう
培養jたは通気せずにゆるく撹拌する培養のいずれを用
いてもよい。培養液を通気撹拌する場合は該培養液に消
泡剤を0.5 % (重量/容量チ)加えるのが好まし
い。また培養温度は30〜40℃、好ましくは35〜3
8℃に保温する。
In the culture of the present invention, any of culture with aeration and stirring of the culture solution, culture with shaking, or culture with gentle stirring without aeration may be used. When the culture solution is aerated and stirred, it is preferable to add 0.5% (weight/volume) of an antifoaming agent to the culture solution. The culture temperature is 30-40°C, preferably 35-30°C.
Keep warm at 8℃.

ヒアルロン酸生産菌の生育にともなって生成する有機酸
のために該培養液のPHが低下するので、水酸化ナトリ
ウムなどのアルカリ水溶液またはアンモニア水を加えて
該培養液のPHを6.5以上   7.5未満の範囲の
指定したPH1好ましくはPH7,0にPHコントロー
ラーにて自動的に連続制御する。
Since the pH of the culture solution decreases due to the organic acid produced as the hyaluronic acid producing bacteria grow, add an alkaline aqueous solution such as sodium hydroxide or aqueous ammonia to adjust the pH of the culture solution to 6.5 or higher.7 Automatically and continuously control the specified PH1, preferably PH7.0, in a range of less than .5 using a PH controller.

2〜3日間このようにして培養するとヒアルロン酸生産
菌の生育がほぼ停止し、該培養液のPHが7.5以上に
上昇してくる。この時点で、該培養液にさらに糖類を2
〜7%、好ましくは5チ(重量/容量%)添加する。
When cultured in this manner for 2 to 3 days, the growth of the hyaluronic acid-producing bacteria almost stops, and the pH of the culture solution rises to 7.5 or higher. At this point, add 2 more sugars to the culture solution.
~7%, preferably 5% (weight/volume %) is added.

用いる糖類としてはブドウ糖、果糖、ガラクトース、乳
糖、シヨ糖および廃糖蜜などの糖類の1種または2種以
上の混合物が用いられる。
The saccharide to be used is one or a mixture of two or more of saccharides such as glucose, fructose, galactose, lactose, sucrose, and blackstrap molasses.

該糖類を添加すると、ヒアルロン酸の生成にともなって
該培養液の粘度が次第だ上昇してくる。
When the saccharide is added, the viscosity of the culture solution gradually increases as hyaluronic acid is produced.

該糖類の添加後、該培養液の粘度の上昇が停壮した時点
で、該培養液に該培養液と同容量以」10倍量未満のイ
オン交換水を加えて希釈し、遠心分離もしくはろ過によ
りヒアルロン酸生漉菌の菌体を除去する。その後肢ろ液
を限外ろ望エチルアルコールによる沈殿分別ついで界面
だ性剤による分画、イオン交換クロマトグラフィー、ゲ
ルろ過クロマトグラフィー等の公知の1段により精製す
ることにより精製ヒアルロン酎を得ることができる。
After the addition of the saccharide, when the increase in the viscosity of the culture solution has stopped, the culture solution is diluted by adding ion-exchanged water in an amount equal to or less than 10 times the volume of the culture solution, and then centrifuged or filtered. The bacterial cells of the hyaluronic acid bacteria are removed by filtration. Purified hyaluronan liquor can be obtained by purifying the hindlimb filtrate by ultrafiltration, precipitation fractionation using ethyl alcohol, fractionation using an interfacial agent, ion exchange chromatography, gel filtration chromatography, etc. can.

以上記述した本発明のヒアルロン酸の裏造湖によれば、
従来の培養法によるヒアルロン酸C生産量が培養液1)
当り0.3〜1.09であるCにくらべ、培養液1)”
4す5〜61と5倍以」の生産量が得られることが判明
し、本発明の打着な効果が確認された。
According to the hyaluronic acid lining of the present invention described above,
The amount of hyaluronic acid C produced by the conventional culture method is 1)
Compared to C, which is 0.3 to 1.09 per cent, culture solution 1)"
It was found that a production amount of 4.5 to 61 times more than 5 times could be obtained, confirming the great effect of the present invention.

以下、実施例および比較例により本発明を具体的に説明
するが、本発明はこれにより限定されるものではない。
EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples and Comparative Examples, but the present invention is not limited thereto.

、  実施例1、比較例1 ブドウ糖2.0%、牛新生児血f41.5容量%、リン
ciIXカリウム0.3%5 リン酸2カリウム0.2
チ、チオ硫酸ナトリウムo、o1)%、硫酸マグネシウ
ム7水塩0.01%、亜硫酸ナトリウム0.002チお
よび大豆油1%(ただし血清のφ以外のチは重量/容量
チを表わす。)からなる培養液1、51 (PH7,O
)にストレプトコッカス・エクイの前培養液loomj
を接種し、毎分300回転、通気ft0.7 vvm 
、温度35℃で培養した。
, Example 1, Comparative Example 1 Glucose 2.0%, Newborn Bovine Blood F4 1.5% by volume, Potassium phosphorus ciIX 0.3%5 Dipotassium phosphate 0.2
From H, sodium thiosulfate o, o1)%, magnesium sulfate heptahydrate 0.01%, sodium sulfite 0.002H and soybean oil 1% (however, H other than φ in serum represents weight/volume H). Culture solution 1,51 (PH7,O
) to preculture solution of Streptococcus equi roomj
inoculated, 300 revolutions per minute, ventilation ft0.7 vvm
, and cultured at a temperature of 35°C.

該培養液のPHが6.94以下にならないように、6規
定の水酸化ナトリウム水溶液をP)Iコントローラーで
自動的に連続制御しながら加えた。
A 6N aqueous sodium hydroxide solution was added under automatic and continuous control using a P)I controller so that the pH of the culture solution did not fall below 6.94.

40時間後に、ブドウ糖50重量/容fチ水溶液som
lを無菌的にさらに該培養液に加えて10時間培養した
。このときの該培養液の粘度は2cpから10時間抜7
cpK上昇した。その後肢培養液にイオン交換水3.2
jを加えて遠心分離により菌体を除去した。得られた上
澄液に希塩酸を加えてPHを4.0に調整し、中空糸限
外ろ過器にて0.61に濃縮し、さらにイオン交換水に
対して透析した。ついでエチルアルコールによる沈殿分
別、塩化セチルピリジニルアンモニウム処理、イオン交
換セルロファインによるクロマトグラフィー等の公知、
の方法にて精製し% 8.5Iのヒアルロン酸ナトリウ
ムの白色粉末を得た。
After 40 hours, add glucose 50 wt/vol f water solution som.
1 was added aseptically to the culture solution and cultured for 10 hours. The viscosity of the culture solution at this time was 2 cp for 10 hours.
cpK increased. Ion-exchanged water for hindlimb culture medium 3.2
j was added and the bacterial cells were removed by centrifugation. Dilute hydrochloric acid was added to the resulting supernatant to adjust the pH to 4.0, the pH was concentrated to 0.61 using a hollow fiber ultrafilter, and the mixture was further dialyzed against ion-exchanged water. Next, known methods such as precipitation fractionation using ethyl alcohol, treatment with cetylpyridinyl ammonium chloride, and chromatography using ion exchange cellulofine, etc.
It was purified by the method described above to obtain a white powder of sodium hyaluronate with a concentration of 8.5I.

培養液ll当り5.6Iの生産量であった。The production amount was 5.6 I per liter of culture solution.

かくして得たヒアルロン酸の蛋白質含有量は0、051
で、分子量はセファロース6Bによるゲルろ過クロマト
グラフィーで2X10’ダルトらないように、6規定の
水酸化ナトリウム水溶液をPHコントローラーで自動的
に連続制御しながら40時間培養し、その後引きつづき
PHが7.5以上になってもブドウ糖の添加をせず、そ
のままの状態でさらに10時間培養を続けた。
The protein content of the hyaluronic acid thus obtained was 0.051
The molecular weight was determined by gel filtration chromatography using Sepharose 6B to ensure that the pH was 2x10. Even when the temperature reached 5 or higher, the culture was continued for another 10 hours without adding glucose.

該培養液を実施例1と同様の処理、精製を行ない、0.
9gの精製ヒアルロン酸ナトリウムの白色粉末を得た。
The culture solution was treated and purified in the same manner as in Example 1, and 0.
9 g of purified sodium hyaluronate white powder was obtained.

培養液1)当、90.6 IIの生産量であった。The production amount of culture solution 1) was 90.6 II.

以上that's all

Claims (2)

【特許請求の範囲】[Claims] (1)ヒアルロン酸を生産する能力を有する微生物を培
養液中で培養するに当り、培養液のPHを6.5以上7
.5未満の指定したPH以下にならないように自動的に
PHの連続制御をしながら培養し、PHが7.5以上に
なつた時点で糖類をさらに添加して培養することによつ
て培養液中にヒアルロン酸を生成蓄積せしめることを特
徴とする発酵法によるヒアルロン酸の製造法。
(1) When culturing microorganisms that have the ability to produce hyaluronic acid in a culture solution, the pH of the culture solution should be 6.5 or more and 7.
.. By culturing while automatically continuously controlling the pH so that it does not fall below a specified pH of less than 5, and when the pH reaches 7.5 or higher, further sugars are added and cultured. A method for producing hyaluronic acid using a fermentation method, which is characterized by producing and accumulating hyaluronic acid.
(2)糖類としてブドウ糖、果糖、ガラクトース、乳糖
、シヨ糖または廃糖蜜から選ばれた1以上を用いる特許
請求の範囲第(1)項に記載の発酵法によるヒアルロン
酸の製造法。
(2) A method for producing hyaluronic acid by the fermentation method according to claim (1), using one or more selected from glucose, fructose, galactose, lactose, sucrose, or blackstrap molasses as the saccharide.
JP18609084A 1984-09-05 1984-09-05 Production of hyaluronic acid through fermentation process Pending JPS6163294A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP18609084A JPS6163294A (en) 1984-09-05 1984-09-05 Production of hyaluronic acid through fermentation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18609084A JPS6163294A (en) 1984-09-05 1984-09-05 Production of hyaluronic acid through fermentation process

Publications (1)

Publication Number Publication Date
JPS6163294A true JPS6163294A (en) 1986-04-01

Family

ID=16182188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18609084A Pending JPS6163294A (en) 1984-09-05 1984-09-05 Production of hyaluronic acid through fermentation process

Country Status (1)

Country Link
JP (1) JPS6163294A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322121C (en) * 1997-10-31 2007-06-20 俄克拉何马大学董事会 Hyaluronan synthase gene and uses thereof
CN1327894C (en) * 1998-04-02 2007-07-25 俄克拉何马大学董事会 Nucleic acid encoding hyaluronan synthase and method of use
JP2012040001A (en) * 2010-07-21 2012-03-01 Kikkoman Corp Method for producing hyaluronic acid

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322121C (en) * 1997-10-31 2007-06-20 俄克拉何马大学董事会 Hyaluronan synthase gene and uses thereof
CN1327894C (en) * 1998-04-02 2007-07-25 俄克拉何马大学董事会 Nucleic acid encoding hyaluronan synthase and method of use
JP2012040001A (en) * 2010-07-21 2012-03-01 Kikkoman Corp Method for producing hyaluronic acid

Similar Documents

Publication Publication Date Title
JPS60251898A (en) Preparation of hyaluronic acid by fermentation method
US5071751A (en) Process for preparing hyaluronic acid
US4885244A (en) Method of producing hyaluronic acid
DE3038219A1 (en) METHOD FOR PRODUCING ISOMALTULOSE (6-O- (ALPHA) -D-GLUCOPYRANOSIDO-D-FRUCTOSE) WITH THE AID OF IMMOBILIZED BACTERIA CELLS
JPS6394988A (en) Production of hyaluronic acid
JPH02234689A (en) Production of hyaluronic acid
JPS6163294A (en) Production of hyaluronic acid through fermentation process
US2975104A (en) Medium and method for producing and isolating hyaluronic acid
JPS63123392A (en) Production of hyaluronic acid
JPH062073B2 (en) Hyaluronic acid manufacturing method
US4377637A (en) Method for producing a low viscosity xanthan gum
CN106893749B (en) Method for improving hyaluronic acid yield by externally adding metabolite in fermentation process
US3044940A (en) Process for enzymatic synthesis of dextran
JPS61219394A (en) Production of hyaluronic acid through fermentation
JPS6115698A (en) Preparation of hyaluronic acid
JPH0753117B2 (en) Hyaluronic acid manufacturing method
JPS6328398A (en) Production of hyaluronic acid
JPH0418839B2 (en)
JP2560257B2 (en) Method for producing chitosan-chitin hollow fiber
JPS63141594A (en) Production of hyaluronic acid
JP3973312B2 (en) Method for producing hyaluronic acid by fermentation
JPH02245193A (en) Production of alkali salt of hyaluronic acid having low polymerization degree
JPH0746992A (en) Production of hyaluronic acid
JPS62215397A (en) Production of hyaluronic acid
JPH044868B2 (en)